Organovo Moving To NYSE

San Diego-based biotechnology developer Organovo Holdings, which is developing 3D, bioprinting technology, said today that it is moving from the OTC markets to the New York Stock Exchange. Organovo said it will move trading of its stock, under the symbol ONVO, to the NYSE MKT, the NYSE's small growth company exchange. Organovo is developing 3D, bio-printing technology aimed at creating human tissues in 3D. The company is currently aiming its technology at accelerating the drug delivery process.